Skip to main content
Top
Published in: Drugs & Aging 12/2011

01-12-2011 | Commentary

Clinical Inertia Remains a Problem

Authors: Robin Klein, William T. Branch Jr., MD

Published in: Drugs & Aging | Issue 12/2011

Login to get access

Excerpt

Described by Isaac Newton in the 1600s, the principle of inertia is one of the fundamental principles of physics and refers to the resistance of an object to change. Applying this principle to the realm of medicine, clinical inertia refers to the failure of healthcare providers to intervene when indicated. The term first used by Phillips et al.[1] at our institution describes the phenomenon that occurs when physicians do not intensify treatment when clinically indicated. Possible explanations for this phenomenon put forth by Phillips et al.[1] include an overestimation of care provided, the use of ‘soft’ reasons to justify nonintervention and a lack of understanding of appropriate clinical guidelines. Some contend that clinical inertia does not adequately represent the complexity of the physician-patient encounter.[2] While inertia implies a failure on the part of the physician to act in patients’ best interest, in actuality, physicians are actively prioritizing the competing demands of patient concerns and symptomatic problems.[2] Reducing this interaction to a checklist of interventions indicated by clinical guidelines minimizes the multifaceted interplay that is the primary care visit. …
Literature
1.
go back to reference Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001; 135(9): 825–34PubMed Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001; 135(9): 825–34PubMed
2.
go back to reference Parchman ML, Pugh JA, Romero RL, et al. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 2007; 5(3): 196–201PubMedCrossRef Parchman ML, Pugh JA, Romero RL, et al. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 2007; 5(3): 196–201PubMedCrossRef
3.
go back to reference Zeimer DC, Miller CD, Rhe MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ 2005; 31(4): 564–71CrossRef Zeimer DC, Miller CD, Rhe MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ 2005; 31(4): 564–71CrossRef
4.
go back to reference Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med 2004; 21: 150–5PubMedCrossRef Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med 2004; 21: 150–5PubMedCrossRef
5.
go back to reference Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, et al. Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. Drugs Aging 2011; 28(12): 981–92PubMedCrossRef Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, et al. Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. Drugs Aging 2011; 28(12): 981–92PubMedCrossRef
6.
go back to reference Branch WT, Higgins S. Clinical inertia: hard to move it forward. Rev Esp Cardiol 2010; 63(12): 1399–401PubMedCrossRef Branch WT, Higgins S. Clinical inertia: hard to move it forward. Rev Esp Cardiol 2010; 63(12): 1399–401PubMedCrossRef
Metadata
Title
Clinical Inertia Remains a Problem
Authors
Robin Klein
William T. Branch Jr., MD
Publication date
01-12-2011
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 12/2011
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/11598370-000000000-00000

Other articles of this Issue 12/2011

Drugs & Aging 12/2011 Go to the issue

Acknowledgments

Acknowledgement

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.